title: Does thalamotomy alter the course of Parkinson's disease?
authors.affiliation: Division of Neurosurgery, Toronto Hospital, Canada.
authors.forename: R R
authors.initials: RR
authors.lastname: Tasker
authors.forename: G C
authors.initials: GC
authors.lastname: DeCarvalho
authors.forename: C S
authors.initials: CS
authors.lastname: Li
authors.forename: J R
authors.initials: JR
authors.lastname: Kestle
mesh_terms: D000328:Adult; D017668:Age of Onset; D000368:Aged; D000978:Antiparkinson Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D018450:Disease Progression; D005260:Female; D005500:Follow-Up Studies; D007839:Functional Laterality / Q000502:physiology; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009127:Muscle Rigidity / Q000209:etiology / Q000628:therapy; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy / Q000601:surgery*; D013788:Thalamus / Q000601:surgery*; D016896:Treatment Outcome; D014202:Tremor / Q000209:etiology / Q000628:therapy
chemical_list: D000978:Antiparkinson Agents; D007980:Levodopa